Fair use 

KIHT –Contributing To India Vision 2020 Through Healthcare

In true spirit, Dr. A.P.J. Abdul Kalam, fondly known as the People’s President and the Missile Man, had envisioned a Developed India through his India Vision 2020 document.

Healthcare was known as a key focus space to reach this vision of a Developed Republic of India. Indigenous, targeted R&D to solve for health care issues in the Republic of India was and is that the would like of the hour. Addressing a gathering in the urban center on January ten, 2010, Dr.Kalam stressed on he would like cheap health care to beat the Republic of India.
Kalam Institute of Health Technology (KIHT), named when this visionary somebody ejaculate national leader,  was set up with the support of Biotechnology trade analysis help Council (BIRAC), a Public Sector Enterprise of Department of Biotechnology to bring enhanced access to cheap health merchandise to voters and thriving medical devices producing sector in the Republic of India. KIHT works towards enabling the medical device trade-in Republic of India that is basically import-dependent resulting in high prices of health care. KIHT works on three core areas of a) Facilitating targeted R&D b) Technology transfer enabling upmarket prototypes c) Market access which can lead to access to health care for patients. galvanized by the vision of Dr.Kalam creating health care cheap and obtainable is at the core of the KIHT philosophy.

KIHT will facilitate focused research on Critical Technology Links(CTLs) of medical devices. As a country,  it is imperative that investments into R&D are made in areas where there is maximum benefit for Indian society. KIHT organizes regular workshops where experts from industry and academia meet to brainstorm key areas of research where India is dependent on Imports. The findings of these sessions are then shared with funding agencies to ensure funds reach critical research areas. The Kalam-Raju stent was developed indigenously by Dr.Kalam and his team in collaboration with Dr. B. Soma Raju of the Care Foundation is a  great example of industry-academia collaboration. India’s import dependency on cardiac stents was making such stents unaffordable. This Kalam-Raju stent brought the cost of stents down by almost 75%. KIHT  will be facilitating focused research on technologies based on the burden of disease and which are high import dependent through their Cell for Research & Development (CRD). Facilitating focused and target-oriented R&D  by providing critical knowledge to relevant institutions.

 R&D  towards new product development wants to maneuver from prototypes to full-fledged products which may then truly reach patients. KIHT  through its Cell for Technology Transfer (CTT) works towards enabling this technology transfer. analysis organizations,  individual innovators, start-ups, tutorial institutes will establish and partner with applicable corporations with the facilitate of the CTT  team at KIHT for exploitation of their innovations. The money thought received for such innovations through exploitation will then be funneled back to change more innovation so making an associate scheme that fosters innovation. Dr.Kalam in an associate address on the occasion of Technology Day 2006, known technology transfer as a key stage in the poignant economic fight of a product. The CTT  team aims to come through palmy technology transfers within the field of medical devices.

The Kalam-Raju pill developed once more by Dr.Kalam and Dr. B Soma Raju served delivery of the right medical aid through technology in addition to access to an information platform. The pill enabled primary level tending employees to create upon choices so up tending access and quality. Drawing a parallel within the medical device house the Cell for Innovation and Market Access (CIM)  aims at enabling the creation and adoption of medical device-specific trade standards,  technology upgrades in producing, talent development programs which can lead to Indian products being at par with international competitors and so enabling economic viability and improved delivery of tending.

CIM will work towards addressing considerations like trade barriers, technical barriers, operational challenges which may impair the production and trade of medical devices.

KIHT is operating towards the goal of cheap and accessible tending for all assets within the Bharat Vision 2020 document. However, this can’t be achieved by one entity. within the health care sector the customers, tending suppliers,  insurance suppliers all ought to invest in building the scheme across best practices, information sharing, and empowering the patient to create upon choices. Sustaining, evolving, maturing the entire tending system in Bharat may be a  project for all stakeholders to drive cohesively.

Courtesy: Kalam Institute of Health Technology